We could have filled this page with the certificates from our vial catalogue. They are real, they are independent, and they would be completely irrelevant to what you are buying — a different manufacturer, a different product, and a different set of things that can go wrong. So here is the actual position instead.
Testing on the filled unit is commissioned as part of the first production run. No allocation ships before those results are in your hands.
Ask the wholesale deskOur archived reports cover lyophilised vials from a different supplier. Three things change when the same compound arrives pre-filled, and each one breaks the chain of evidence.
Every test below is performed on the filled unit — the device you would hand a patient — not on the raw peptide before it goes in.
Confirms the peptide in the pen is the peptide on the label. The single test no other result means anything without.
Run on the filled solution, not on the powder before filling. A purity figure from before the fill says nothing about what is in the device.
A pre-filled injector is a sealed sterile presentation. This has no equivalent in the vial line, where the buyer reconstitutes and carries that risk.
Bacterial endotoxin survives sterilisation. Reported per millilitre against the dose the device actually delivers.
A dose-graduated pen is only accurate if the fill matches the label claim. Verified per lot rather than per unit.
The one that decides shelf life and storage. Peptide in solution degrades where lyophilised powder does not — particularly the GLP-1 class.
No result values appear anywhere on this site, because there are none yet. When a figure shows up here it will be attached to a lot number you can match against the carton in your hand.
Including us. If a supplier cannot answer these about a pre-filled product, that is the answer.